[go: up one dir, main page]

HUP0100937A2 - Többszörösen elágazó peptidkonstrukciókat tartalmazó liposzómák és alkalmazásuk humán immundeficiencia vírus ellen - Google Patents

Többszörösen elágazó peptidkonstrukciókat tartalmazó liposzómák és alkalmazásuk humán immundeficiencia vírus ellen

Info

Publication number
HUP0100937A2
HUP0100937A2 HU0100937A HUP0100937A HUP0100937A2 HU P0100937 A2 HUP0100937 A2 HU P0100937A2 HU 0100937 A HU0100937 A HU 0100937A HU P0100937 A HUP0100937 A HU P0100937A HU P0100937 A2 HUP0100937 A2 HU P0100937A2
Authority
HU
Hungary
Prior art keywords
immunodeficiency virus
human immunodeficiency
containing multiple
multiple branch
liposomes
Prior art date
Application number
HU0100937A
Other languages
English (en)
Inventor
Bonabes-Olivier De Rouge
Original Assignee
Cellpep S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cellpep S.A. filed Critical Cellpep S.A.
Publication of HUP0100937A2 publication Critical patent/HUP0100937A2/hu
Publication of HUP0100937A3 publication Critical patent/HUP0100937A3/hu
Publication of HU224715B1 publication Critical patent/HU224715B1/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/162—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

A találmány tárgyát többszörösen elágazó peptidkonstrukciókat(<Multiple Branch Peptide Construction<, MBPC) tartalmazó liposzómákképezik, amelyek alkalmasak humán immundeficiencia vírus (HIV) okoztafertőzés kezelésére. Az MBPC-k prezentálása liposzómákban lényegesenmegnöveli az MBPC-k aktivitását. A találmány tárgyát képezik atalálmány szerinti liposzómákat tartalmazó gyógyászati készítmények. Atalálmány szerinti liposzómák, gyógyászati készítmények és eljárásokHIV-fertőzés kezelésére alkalmazhatók. Ó
HU0100937A 1997-12-31 1998-12-28 Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus HU224715B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9727424.5A GB9727424D0 (en) 1997-12-31 1997-12-31 Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus
PCT/EP1998/008579 WO1999034777A1 (en) 1997-12-31 1998-12-28 Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus

Publications (3)

Publication Number Publication Date
HUP0100937A2 true HUP0100937A2 (hu) 2001-06-28
HUP0100937A3 HUP0100937A3 (en) 2004-06-28
HU224715B1 HU224715B1 (en) 2006-01-30

Family

ID=10824280

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0100937A HU224715B1 (en) 1997-12-31 1998-12-28 Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus

Country Status (13)

Country Link
US (1) US6610304B1 (hu)
EP (1) EP1043974B1 (hu)
JP (1) JP2002500175A (hu)
AT (1) ATE215361T1 (hu)
CA (1) CA2317107C (hu)
DE (1) DE69804674T2 (hu)
DK (1) DK1043974T3 (hu)
ES (1) ES2174548T3 (hu)
GB (1) GB9727424D0 (hu)
HU (1) HU224715B1 (hu)
PT (1) PT1043974E (hu)
WO (1) WO1999034777A1 (hu)
ZA (1) ZA9811877B (hu)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9727424D0 (en) * 1997-12-31 1998-02-25 Armel Sa Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus
US7285621B2 (en) * 1999-06-29 2007-10-23 Ambrilia Biopharma Multiple branch peptide construction
US20060229433A1 (en) * 2003-05-20 2006-10-12 Cellpep Sa Modified antiviral peptides with increased activity and cell membrane affinity
US7676835B2 (en) * 2004-08-31 2010-03-09 International Business Machines Corporation System and method for regulating access to objects in a content repository
WO2010135714A2 (en) 2009-05-22 2010-11-25 The Methodist Hospital Research Institute Methods for modulating adipocyte expression using microrna compositions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5709879A (en) * 1990-06-29 1998-01-20 Chiron Corporation Vaccine compositions containing liposomes
IL110929A0 (en) * 1993-09-13 1994-11-28 Armel Sa Multiple branch peptide constructions and pharmaceutical compositions containing them
GB9627114D0 (en) * 1996-12-31 1997-02-19 Centre Nat Rech Scient Multiple branch peptide constructions
GB9727424D0 (en) * 1997-12-31 1998-02-25 Armel Sa Liposomes containing multiple branch peptide constructions for use against human immunodeficiency virus

Also Published As

Publication number Publication date
CA2317107A1 (en) 1999-07-15
HU224715B1 (en) 2006-01-30
DE69804674T2 (de) 2002-10-31
EP1043974A1 (en) 2000-10-18
DE69804674D1 (de) 2002-05-08
ZA9811877B (en) 1999-08-05
US6610304B1 (en) 2003-08-26
GB9727424D0 (en) 1998-02-25
ES2174548T3 (es) 2002-11-01
ATE215361T1 (de) 2002-04-15
CA2317107C (en) 2008-03-11
DK1043974T3 (da) 2002-07-15
HUP0100937A3 (en) 2004-06-28
PT1043974E (pt) 2002-09-30
JP2002500175A (ja) 2002-01-08
WO1999034777A1 (en) 1999-07-15
EP1043974B1 (en) 2002-04-03

Similar Documents

Publication Publication Date Title
HUP0300814A2 (hu) Peptidszelekciós módszer
ATE264914T1 (de) Antivirale proteine, dafür kodierende dna, und deren verwendung
DK1289517T3 (da) Farmaceutiske sammensætninger indeholdende cannabidiolderivater
CY1106152T1 (el) Νεα ανοσογονα αντι-hiv (ανατοξινες), μεθοδοι παρασκευης και εφαρμογη στην προληψη και στην αγωγη του aids
HUP0002224A1 (hu) Virusellenes hatású benzimidazol-származékok
NO20020571L (no) Peptider som blokkerer infeksjonsevnen, og fremgangsmåter for anvendelse av disse
ATE65505T1 (de) Biologisch aktive fragmente von humanem antihaemophiliefaktor, methode zu ihrer herstellung und pharmazeutische praeparate.
ATE198050T1 (de) Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia
DE69531499D1 (de) Liposomenzubereitungen zur behandlung von viruserkrankungen
HUP0100937A2 (hu) Többszörösen elágazó peptidkonstrukciókat tartalmazó liposzómák és alkalmazásuk humán immundeficiencia vírus ellen
PL326629A1 (en) Application of flupyrtin in prophylaxy and therapy of deseases associated with damaged hematopoietic cellular system
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
HUP9900945A2 (hu) Nukleozidanalógok herpes simplex vírus fertőzések kombinációs terápiájában
EA200400535A1 (ru) ПОДАВЛЕНИЕ ВИРУСОВ n-ДОКОСАНОЛОМ
WO1997026880A3 (en) Use of a combination of delavirdine and one or more protease inhibitors in hiv-1 infected patients
KR950702838A (ko) 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
EA199800770A1 (ru) Лекарственный препарат для терапевтического лечения вирусного гепатита
EP1073461A4 (en) VIRAL CHIMES COMPRISING GENETIC ELEMENTS OF CAEV AND HIV-1
ATE207364T1 (de) Caprin arthritis-enzephalitis virus enthaltende vakzine und verwendung zur immunschutz gegen hiv- 1 infektion
Horgan et al. Aspergillosis
ATE293445T1 (de) Herstellung reiner stereoisomere von tricyclo- (5.2.1.0(2.6) )-dec-9-yl-xanthogenat sowie deren verwendung als arzneimittel
GR3029523T3 (en) Peptides that block human immunodeficiency virus infections and methods of use thereof
TNSN03066A1 (en) Natural antibodies active against hiv virus
RU95102712A (ru) Липосомный фармацевтический препарат и лечебно-профилактический крем на его основе
Scheibel Five-drug or six-drug antiretroviral therapy--conversation with Steven Scheibel, MD Interview by John S. James

Legal Events

Date Code Title Description
HFG4 Patent granted, date of granting

Effective date: 20051205

MM4A Lapse of definitive patent protection due to non-payment of fees